Literature DB >> 1423192

Coagulation-fibrinolysis system and markers of collagen metabolism in lung cancer.

E C Gabazza1, O Taguchi, T Yamakami, M Machishi, H Ibata, K Tsutsui, S Suzuki.   

Abstract

BACKGROUND: Evidence suggests that the fibrinolysis system and peritumoral connective tissue play important roles in tumor spread.
METHODS: In this study, the authors evaluated the following parameters in 30 consecutive patients with lung cancer: thrombin-antithrombin complex (TAT), cross-linked fibrin split products D-dimer (DD), plasmin-alpha 2-antiplasmin inhibitor complex (PAP), and two antigens related to connective tissue, the aminoterminal propeptide of type III procollagen (PIIIP) and the 7S domain of type IV collagen (7S-collagen).
RESULTS: Each parameter was increased significantly in the patients with cancer compared with the control subjects. Except for PIIIP, their concentration in blood was elevated to a significantly greater extent in the patients with distant metastases. The PAP concentration correlated well with the plasma concentration of TAT (r = 0.5; P < 0.01) and DD (r = 0.9; P < 0.0001). There was also a strong correlation between the serum concentrations of PIIIP and 7S-collagen (r = 0.7; P < 0.001). In patients with localized disease, DD levels were correlated significantly with those of PIIIP (Spearman rank-order correlation [rs] = 0.6; P < 0.025) and 7S-collagen (rs = 0.6; P < 0.01). In the group with disseminated metastases, there was a significant inverse relationship between serum PAP concentrations and serum concentrations of 7S-collagen (rs = -0.6; P < 0.025).
CONCLUSIONS: These results confirm the presence of a subclinical chronic activation of the parameters of intravascular clotting-fibrinolysis and alterations in the extracellular matrix of patients with lung cancer. These parameters may be useful as indicators of the clinical progression of malignant disease, particularly of lung cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1423192     DOI: 10.1002/1097-0142(19921201)70:11<2631::aid-cncr2820701111>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Association between plasma levels of D-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders.

Authors:  Rafael Noal Moresco; Ronald Halla Júnior; Luis Cláudio Rosa Vargas; Lúcia Mariano da Rocha Silla
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

2.  Fibrinolytic activity of earthworms extract (G-90) on lysis of fibrin clots originated from the venous blood of patients with malignant tumors.

Authors:  T M Hrzenjak; M Popović; L Tiska-Rudman
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

3.  Paracrine production of IL-6 promotes a hypercoagulable state in pancreatic cancer.

Authors:  Silu Wang; Linyong Du; Hao Chen; Xing Zhang; Bicheng Chen; Lihong Yang
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

Review 4.  Hemostatic changes in patients with brain tumors.

Authors:  L Thoron; E Arbit
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Estimation of the levels of D-dimer by use of an alternative method based in the reaction time of fibrinogen/fibrin degradation products assay.

Authors:  Rafael Noal Moresco; Luis Cláudio Rosa Vargas; Lúcia Silla
Journal:  J Thromb Thrombolysis       Date:  2006-12-09       Impact factor: 5.221

6.  Clinical characteristics and prognostic analysis of Lung Cancer patients with Hypercoagulability: A single-center, retrospective, real-world study.

Authors:  Yunfei Ma; Guangda Li; Xiaoxiao Li; Yu Gao; Tongjing Ding; Guowang Yang; Yi Zhang; Jiayun Nian; Mingwei Yu; Xiaomin Wang
Journal:  J Cancer       Date:  2021-03-19       Impact factor: 4.207

7.  Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer.

Authors:  C C Kirwan; G McDowell; C N McCollum; S Kumar; G J Byrne
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

8.  Effect of gender on coagulation functions: a study in metastatic colorectal cancer patients treated with bevacizumab, irinotecan, 5-Fluorouracil, and leucovorin.

Authors:  Cemil Bilir; Hüseyin Engin; Yasemin Bakkal Temi
Journal:  Adv Hematol       Date:  2014-08-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.